Using genetic information to determine disease risk and predisposition, diagnosis, likely outcomes, and to help select and prioritise possible treatments.
Dr Jane Tiller explains the significance of Australia's new legislation about the use of genetic test results in life insurance...
Former consultant embryologist Jane Blower was recognised in this year's King's Birthday Honours List alongside Professors Andrew Mumford, Bruce Whitelaw and Gareth Evans...
Patients diagnosed with breast cancer may be able to safely avoid chemotherapy if a genomic test indicates they are at low risk of their cancer returning, according to findings presented at a major cancer conference...
As genomic testing becomes increasingly embedded in routine NHS care, this article examines the expanding role of genetic counsellors and introduces a new toolkit supporting their integration into mainstream clinical practice...
Genetic Alliance UK has been reviewing the 168-page document to understand what the Plan means for the 3.5 million people living with genetic, rare, and undiagnosed conditions in the UK...
Genomics has the potential to reshape the NHS into a more proactive, cost-efficient, and patient-responsive system, writes Zeenat Beebeejaun. But it can only do so if built on a foundation of trust, transparency, and fairness...
Dr Natalie Banner is host to researchers and participants of the EPPiGen Project to explore the realities of being ethically prepared in the era of genomic medicine...
A Position Statement has been published to describe best practice for ensuring consistent delivery of genomic testing for rare diseases...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
